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Strengths and limitations of this study
 ► We used a large population cohort, with detailed 
early and mid- life data which were linked to high- 
quality Scottish hospital episode and mortality data.
 ► The advantages of using administrative data include 
being able to achieve a large sample size at rela-
tively low cost, better population coverage and the 
ability to follow- up over long periods of time.
 ► We did not have regular status updates for the study 
population; therefore, we acknowledge that some of 
our population may have temporarily resided outside 
of Scotland during the 5- year lookback period and 
thus any healthcare contacts would not be recorded.
AbStrACt
Objectives Multimorbidity is the coexistence of two or 
more health conditions in an individual. Multimorbidity in 
younger adults is increasingly recognised as an important 
challenge. We assessed the prevalence of secondary 
care multimorbidity in mid- life and its association with 
premature mortality over 15 years of follow- up, in the 
Aberdeen Children of the 1950s (ACONF) cohort.
Method A prospective cohort study using linked electronic 
health and mortality records. Scottish ACONF participants 
were linked to their Scottish Morbidity Record hospital 
episode data and mortality records. Multimorbidity was 
defined as two or more conditions and was assessed using 
healthcare records in 2001 when the participants were 
aged between 45 and 51 years. The association between 
multimorbidity and mortality over 15 years of follow- up (to 
ages 60–66 years) was assessed using Cox proportional 
hazards regression. There was also adjustment for key 
covariates: age, gender, social class at birth, intelligence 
at age 7, secondary school type, educational attainment, 
alcohol, smoking, body mass index and adult social class.
results Of 9625 participants (51% males), 3% had 
multimorbidity. The death rate per 1000 person- years was 
28.4 (95% CI 23.2 to 34.8) in those with multimorbidity 
and 5.7 (95% CI 5.3 to 6.1) in those without. In relation to 
the reference group of those with no multimorbidity, those 
with multimorbidity had a mortality HR of 4.5 (95% CI 3.4 
to 6.0) over 15 years and this association remained when 
fully adjusted for the covariates (HR 2.5 (95% CI 1.5 to 
4.0)).
Conclusion Multimorbidity prevalence was 3% in mid- life 
when measured using secondary care administrative data. 
Multimorbidity in mid- life was associated with premature 
mortality.
IntrOduCtIOn
Multimorbidity is commonly defined as the 
coexistence of two or more health condi-
tions within an individual.1 2 It is becoming 
an increasing challenge for individuals and 
health and social care services.3–6 Under-
standing its impact across the life course 
forms a crucial part of addressing its impact. 
However, there is a lack of longitudinal 
research into the determinants and outcomes 
of multimorbidity using large study popula-
tions.3 4 7
Studies have shown that while multimor-
bidity prevalence is higher in older adults, 
in terms of absolute numbers there are 
more multimorbid young and middle- aged 
people.8–10 A retrospective cohort study in 
Hong Kong, which used hospital data to 
measure multimorbidity, found that middle- 
aged patients with multimorbidity had a 
greater number of hospital admissions than 
older patients.11 There is recognition of the 
need for greater understanding of the deter-
minants and outcomes of multimorbidity in 
middle- aged adults.11 12
Research in a variety of populations, using 
a range of multimorbidity definitions and 
measures, has found multimorbidity to be 
associated with increased mortality.3 13 14 
However, the relationship between multimor-
bidity in mid- life and premature mortality 
(defined by the WHO as being less than 70 
years)15 is less well characterised. Recent 
analyses have demonstrated that the trend 
for increasing life expectancy observed 
throughout the 20th century in high- income 
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countries has stalled and in some cases reversed.16–19 
Further to this, non- communicable diseases are a signif-
icant source of premature mortality,15 17 indicating that 
exploration of this for multimorbidity is important.
Multimorbidity can be measured in a variety of ways 
(eg, by self- report, using primary care data, using 
prescription data or hospital records) and each captures 
a different burden of multimorbidity.1 2 There is no gold- 
standard measure and so it is important that researchers 
are clear regarding the approach they have taken to 
allow interpretation.2 Multimorbidity measured using 
hospital (secondary care) data provides assessment of the 
burden placed on both individuals and health services. 
Using existing healthcare records (administrative data) 
is a cost- effective route to assess multimorbidity from 
these perspectives.20 Much multimorbidity research using 
secondary care records is based in patient populations 
and much is focused on older adults.11 21–25 Identifying 
whether multimorbidity measured using secondary care 
data in middle- aged adults in the general population is 
associated with premature mortality is a potential route 
by which to identify high- risk individuals and inform 
healthcare and public health research and action.
The Aberdeen Children of the 1950s (ACONF) is a 
large Scottish population- based birth cohort with very 
detailed early and mid- life information.26 Participants 
have been linked to their secondary care administrative 
data (from which secondary care multimorbidity can be 
measured) and mortality records. The aim of this study is 
to assess the prevalence of secondary care multimorbidity 
in mid- life, and its association with premature mortality 
over 15 years of follow- up, in the ACONF cohort.
MethOd
Study design and population
The study reporting followed the REporting of studies 
Conducted using Observational Routinely- collected 
Data (RECORD) guidelines.27 This was a prospective 
cohort study using linked electronic health and mortality 
records.
The ACONF is described in detail elsewhere.26 It 
contains 12 150 individuals born in Aberdeen in the 
North of Scotland, between 1950 and 1956. There are 
data on early life factors such as social class at birth and 
the results of cognitive testing. In 2001, 7184 participated 
in a postal questionnaire, providing self- reported infor-
mation on health, well- being, social and environmental 
characteristics. The ACONF is flagged for deaths and 
embarks across the UK.
Patient and public involvement
No patients or public were directly involved in the 
development of the research question, selection of the 
outcome measures, design and implementation of the 
study or interpretation of the results.
data linkage and data management
Healthcare in Scotland is delivered by the National Health 
Service (NHS), a free at the point of use nationally funded 
universal care system.28 We used Scottish Morbidity 
Record (SMR) hospital episode data from general/
acute (SMR01) and psychiatric (SMR04) admissions to 
measure multimorbidity. We supplemented this with the 
Scottish Cancer Registry (SMR06) which includes data on 
dates of malignant cancer diagnoses.29The SMR01 and 
SMR04 are formed from discharge records. On discharge 
from hospital, the reason for admission and up to five 
supplementary conditions (these can include active and 
historical conditions) are coded using the International 
Classification of Disease (ICD) system. The SMRs are held 
nationally by the Information Services Division (ISD).30 
Death certificate data (including the date of death) is 
held by the National Records of Scotland.31
In Scotland, ISD support the coding process and provide 
training, support, validation and quality assurance checks 
of data. In SMR01 (general and acute admissions), the 
accuracy rate of coding for the ‘Main Condition’ has been 
found to be 89% (not statistically significantly different 
from the ISD- recommended minimum standard of 
90%).32 Specific checking of a range of common condi-
tions (eg, stroke, alcohol misuse and diabetes) found that 
the overall accuracy rate was 96% but almost 20% were 
under- recorded.32
SMR04 (psychiatric admissions) accuracy is lower than 
SMR01, with ‘Main Condition’ found to be 78% nation-
ally and ‘Other Conditions’ at 73%.33 Under- recording of 
key psychiatric and non- psychiatric diagnoses (including 
dementia and mood disorders) was almost 30%.33
The SMR06 cancer registry has not been quality 
assessed by ISD in the same manner. However, research 
suggests quality is high. A study found agreement in 
coding of the major tumour site category in 97% of cases, 
when comparing the registry to the medical record.34In 
our own assessment of the agreement between SMR01 
and SMR06, we found it to be 99% with kappa statistic of 
0.75 indicating substantial agreement (see online supple-
mentary table 1).
Linkage of individuals to electronic health and mortality 
records was achieved using the Community Health Index 
(CHI). The CHI number is a unique 10- digit identifier 
allocated to a patient on first registration with the NHS 
system. ISD conducted seeding (attaching CHI numbers) 
of the ACONF members’ data, with 89% of the original 
12 150 seeded. ISD then conducted linkage between the 
ACONF and the SMRs and mortality data using the CHI 
number (deterministic matching).
The study population and the data linkage processes are 
summarised in figure 1. As multimorbidity is measured 
from Scottish SMR data in 2001, we included all ACONF 
participants living in Scotland on 30 September 2001, 
who were CHI seeded. Furthermore, to conduct survival 
analysis for mortality, study participants were those who 
had complete follow- up data to 2016 (were known to be 
resident in Scotland or the UK or who had a recorded 
death from Scotland or elsewhere). Those who were lost 
to follow- up or who embarked from the UK between 2001 
and 2016 were excluded (n=50) as the precise date of loss 
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Figure 1 Flow chart of ACONF study population and data 
linkage. *Lost to follow- up or embarked from the UK. ACONF, 
Aberdeen Children of the 1950s; CHI, Community Health 
Index; SMR, Scottish Morbidity Record.
to follow- up/embarkation was unknown and any subse-
quent death will not be detected.
The Grampian Data Safe Haven (DaSH) oversaw data 
management and security. To quality assure the linkage 
between the ACONF and administrative data, represen-
tatives from DaSH and ISD viewed a sample of the iden-
tifiers from the original cohort and the linked data sets, 
with no discrepancies found. The research team had 
access to an anonymised data set that contained all study 
participants and their linked SMR and death records. 
Data cleaning carried out by the study team included 
checking no admissions had occurred for an individual 
after their death, checking that gender from the SMR 
matched the gender recorded in the original ACONF 
data set and checking that prevalence figures (gender, 
postal questionnaire response and social class at birth) 
matched previous ACONF publications. Minor discrep-
ancies were resolved after discussion with ISD and the 
ACONF study coordinator.
exposure: multimorbidity
Multimorbidity was defined as two or more conditions 
from the Barnett multimorbidity measure, an emerging 
consensus measure of multimorbidity.8 It is a disease 
count measure, developed using Scottish primary care 
specific codes.8 A review of the coding literature was 
combined with codes used commonly by the NHS in Scot-
land to apply ICD codes to each condition. The list of 
conditions, the methodology and ICD codes are given in 
online supplementary table 2.
The index date was 30 September 2001 and a 5- year 
look back was used (to 1 October 1996). The index date 
was selected on the basis of being representative of mid- 
life. A 5- year look back means that any Barnett condi-
tion coded during the 5 years including and prior to the 
index date is recorded as part of the morbidity count. A 
condition was only counted once even if there had been 
multiple occurrences. A lookback period is standard prac-
tice when measuring the prevalence of morbidities using 
administrative data. It is needed because the record of 
the reasons for a single admission will likely miss condi-
tions which are important but happen not to have been 
active during that admission. We set the look back at 
5 years based on the evidence that it is of sufficient length 
to ascertain chronic disease status and to model outcomes 
such as mortality.35 36
The ICD is in its 10th revision (ICD-10), but the ICD-9 
was used by ISD until 1996.37 Therefore, both ICD-9 and 
ICD-10 codes were used in this study.
Outcome: premature mortality
The mortality rate was based on deaths occurring from 
1 October 2001 to 30 September 2016. The death dates 
were sourced from linked Scottish mortality data or from 
routine flagging for deaths in the rest of the UK. Prema-
ture mortality was defined as deaths occurring before 
70 years of age. The full follow- up period available for 
ACONF was to between 60 and 66 years of age.
early-life covariates
Social class at birth
Social class at birth was based on the father’s occupa-
tion at the birth of the participant and is coded using 
the General Register Office’s Occupational classification 
(1950).38 This information was sourced from participant 
birth records in the Aberdeen Maternity and Neonatal 
Databank. Social class categories ranged from I (profes-
sional) to V (unskilled) and there was an additional cate-
gory for those whose fathers were unemployed, unknown, 
disabled or dead at the time of the participant’s birth. 
This latter category combines a diverse range of paternal 
status but all share the characteristic that the father is not 
providing income. Arguably the impact of each would be 
similar in the 1950s, where the father was traditionally the 
main source of financial income for a household. Social 
class is included as it is an important determinant of both 
multimorbidity and mortality.39 40
Childhood intelligence
Routine intelligence tests were carried out at the age of 
7 in the 1950s and 1960s in Aberdeen. The test involved 
using the Moray House Picture Intelligence Tests 
(numbers 1 or 2) to screen for learning disability.26 41 The 
test was age- standardised for Scotland as a whole (mean 
of 100, SD of 15).41 Childhood intelligence is included 
as it is known to be linked to early mortality and with 
a range of morbidities including coronary heart disease 
and stroke.42–44
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Postal questionnaire covariates
Educational attainment
Participants reported their highest qualification, ranging 
from ‘no formal qualifications’ through ‘degree level’. 
Attainment was summarised in five categories. Educa-
tional attainment has been found to be associated with 
multimorbidity and mortality.39 45
Secondary school type
Selective schooling for secondary education was in place 
in Aberdeen in the 1950s and 1960s. The results of child-
hood intelligence tests and teacher assessment were used 
to stream children into ‘elite schools’ (which included 
private schools) for those deemed to be more academi-
cally able and ‘non- elite schools’ for those defined as less 
academically able.46 ‘Elite’ schools consisted of three non- 
private and three private schools, ‘non- elite’ contained 
12 non- private schools, 2 special needs schools and a 
convent. This is included as it influences educational 
attainment.46
Adult social class
The Registrar General’s social classes became the Stan-
dard Occupational Classification in 1990 (SOC90)47 
and the adult social class categories were formed using 
SOC90. Adult social class was categorised in the same 
manner as that of the birth social class (other than not 
including a category for the father being unemployed, 
unknown, disabled or dead). Social class is associated 
with both multimorbidity and mortality.39 40
Adult body mass index (BMI), smoking status and alcohol-related 
hangover frequency
BMI, smoking status and alcohol consumption have been 
shown to be risk factors for morbidity, multimorbidity and 
mortality.48–52 BMI was derived from self- reported height 
and weight using the standard calculation: weight (kg)/
height (m2). Normal weight is classed as a BMI between 
18.5 and 24.9. BMI was a continuous variable. Smoking 
was categorised as current, past and never- smoked. There 
was no question about average alcohol consumption and 
as a proxy a question regarding the frequency of hang-
overs was used (a categorical variable).
Statistical analysis
Analyses were conducted using STATA V.13. Statistical 
significance was set at the 5% level. Baseline character-
istics were summarised by frequencies, proportions and 
95% CIs or means with SDs where appropriate. The 
prevalence of morbidities and of multimorbidity were 
presented. The relationship between each characteristic 
and multimorbidity was assessed using the χ2 test for 
nominal variables, the χ2 test for trend for ordinal vari-
ables and the independent t- test for normally distributed 
continuous variables.
For survival analysis, contributions of risk were 
censored at the earliest of the following: (1) death date 
recorded after 30 September 2001 and (2) 30 September 
2016 (end of the follow- up period). The cohort survival 
by multimorbidity status, from 1 October 2001 to 30 
September 2016, was presented in a Kaplan- Meier 
survival curve. The mortality rate per 1000 person- years 
was calculated. Cox proportional hazards regression was 
used to assess the association between multimorbidity 
in 2001 and mortality rate to 2016. The analysis was first 
conducted unadjusted and then with adjustment for age 
and gender. Finally, there was adjustment for these vari-
ables plus social class at birth, intelligence at age 7 and 
the postal questionnaire variables (highest educational 
attainment, secondary school type, adult social class, BMI, 
smoking status and hangover frequency). HRs with 95% 
CIs were presented.
Missing data
There were no missing data for the exposure or outcome, 
or for age and gender. In the model adjusted by further 
variables, those from the postal questionnaire were 
subject to missing data due to the questionnaire response 
rate. However, there was insufficient information in the 
data set to impute missing values (the data were missing 
not at random (MNAR)). Complete case analysis (CCA) 
was therefore conducted.
ethical approval
The ACONF data set is registered with the National 
Research Ethics Service (NRES) as a research database. 
The North of Scotland NRES confirmed that no further 
ethical approval was required. We gained permission 
from the ACONF steering committee as well as from the 
national ‘Privacy Advisory Committee’ (now called the 
‘Public Benefit and Privacy Panel for Health and Social 
Care’) to link and use Scottish administrative data.
reSultS
The cohort comprised 9625 individuals and contrib-
uted 146 472 person- years at risk over a 15- year follow- up 
period. The baseline characteristics of the population are 
shown in table 1. 51% were males and the mean age was 48 
(range 45–51 years). The majority had a father in ‘social 
class III (skilled manual)’ at their own birth (44%). The 
mean intelligence score was 107 (SD 16.2). Almost 66% 
had responded to the postal questionnaire. The majority 
(72%) attended a ‘non- elite’ school. The single largest 
qualification category was ‘ordinary level’ (29%), and the 
largest adult social class category was ‘I/II (professional/
managerial)’ (39%). The mean BMI was 27 (SD 4.8). The 
largest smoking category was ‘non- smoker’ (48%) and 
most reported having hangovers less than once a month 
(40%) or not at all in the last year (46%).
The prevalence of individual morbidities are presented 
in table 2. The most common conditions were ‘pain’ 
(5%), ‘alcohol misuse’ (1%) and cancer (1%). The least 
common (affecting less than 10 individuals) included 
Parkinson’s disease and dementia.
The baseline characteristics by multimorbidity are 
shown in table 1. The prevalence of multimorbidity was 
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Table 1 Baseline characteristics of ACONF cohort and association with MM status*
Categories (number with complete 
information)
Total 
number
Proportion of 
total within 
characteristic
Number 
with MM
MM 
prevalence 
(%)
MM 
prevalence 
(95% CI)
Association of MM 
with characteristic p 
value
Total 9625 100 253 2.6 2.3 to 3.0
Gender (n=9625)     
  Male 4932 51.2 126 2.6 2.1 to 3.0 0.643
  Female 4693 48.8 127 2.7 2.3 to 3.2
Mean age (years) in September 2001 
(n=9625)
47.8 (SD 1.5), range 45–51 47.9 (SD 1.5), range 45–51 0.259
Social class of the father at birth of the 
participant (n=9625)
    
  I/II (professional/managerial) 812 8.4 17 2.1 1.3 to 3.3 0.055
  III (skilled non- manual) 1041 10.8 31 3.0 2.1 to 4.2
  III (skilled manual) 4256 44.2 95 2.2 1.8 to 2.7
  IV (partly skilled) 1371 14.2 51 3.7 2.8 to 4.9
  V (unskilled) 1644 17.1 47 2.9 2.2 to 3.8
  Unemployed/unknown/disabled/dead 501 5.2 12 2.4 1.4 to 4.2
Mean intelligence score at age 7 (n=9319) 107 (SD 16.2) 100 (SD 16.5) <0.001
Responded to postal questionnaire     
  Yes 6325 65.7 144 2.3 1.9 to 2.7 0.003
  No 3300 34.3 109 3.3 2.7 to 4.0
Secondary school type (n=6107)     
  Non- elite 4411 72.2 102 2.3 1.9 to 2.8 0.383
  Elite 1696 27.8 33 2.0 1.4 to 2.7
Educational attainment (n=6234)     
  Tertiary (degree) 1079 17.3 18 1.7 1.1 to 2.6 0.106
  Tertiary (non- degree) 1006 16.1 24 2.4 1.6 to 3.5
  Advanced level 818 13.1 12 1.5 0.8 to 2.6
  Ordinary level 1781 28.6 41 2.3 1.7 to 3.1
  School leaving/none 1550 24.9 46 3.0 2.2 to 3.9
2001 adult social class (n=6174)     
  I/II (professional/managerial) 2433 39.4 40 1.6 1.2 to 2.2 0.043
  III (skilled non- manual) 1573 25.5 37 2.4 1.7 to 3.2
  III (skilled manual) 1202 19.5 25 2.1 1.4 to 3.1
  IV (partly skilled) 675 10.9 21 3.1 2.0 to 4.7
  V (unskilled) 291 4.7 11 3.8 2.1 to 6.7
2001 mean body mass index (n=5868) 27 (SD 4.8) 27.3 (SD 6.2) 0.073
2001 adult smoking status (n=6310)     
  Current smoker 1743 27.6 62 3.6 2.8 to 4.5 <0.001
  Ex- smoker 1551 24.6 42 2.7 2.0 to 3.6
  Non- smoker 3016 47.8 40 1.3 1.0 to 1.8
2001 adult alcohol- related hangovers in past 
year (n=5928)
    
  At least once a week 152 2.6 5 3.3 1.4 to 7.7 0.105
  1–3 times a month 680 11.5 12 1.8 1.0 to 3.1
  Less than once a month 2373 40.0 34 1.4 1.0 to 2.0
  Not at all in the last year 2723 45.9 61 2.2 1.7 to 2.9
*Figures presented are numbers and proportions unless stated otherwise.
ACONF, Aberdeen Children of the 1950s; MM, multimorbidity.
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Figure 2 Survival curve for multimorbidity from 2001 to 
2016 with indication of number at risk over time.
Table 3 Mortality rate per 1000 person- years in ACONF cohort by multimorbidity status (n=9625)
Multimorbidity status in 2001
Number at 
baseline
Person- years at 
risk Deaths
Death rate per 1000 
person- years 95% CI
Absent 9372 143 200 818 5.7 5.3 to 6.1
Present 253 3272 93 28.4 23.2 to 34.8
Total 9625 146 472 911 6.2 5.8 to 6.6
ACONF, Aberdeen Children of the 1950s.
2.6%. There was no association with age, gender, social 
class at birth, secondary school type, educational attain-
ment, adult BMI or hangover frequency. The mean 
intelligence score at age 7 was lower in those with multi-
morbidity (mean of 100 (SD 16.5) compared with 107 
(SD 16.2), p<0.001). Those who responded to the postal 
questionnaire had a lower prevalence of multimorbidity 
(2.3% (1.9%–2.7%) compared with 3.3% (2.7%–4.0%), 
p=0.003). Those with a lower adult social class had a 
higher prevalence of multimorbidity (p=0.043). For 
example, the prevalence in I/II (professional/manage-
rial) was 1.6% (95% CI 1.2% to 2.2%) and the prevalence 
in V (unskilled) was 3.8% (95% CI 2.1% to 6.7%). There 
was an association between smoking status and multimor-
bidity (p<0.001). For example, those who were current 
smokers had a higher prevalence than those who were 
non- smokers (prevalence of 3.6% (95% CI 2.8% to 4.5%) 
in the former and 1.3% (95% CI 1.0% to 1.8%) in the 
latter).
The survival curve for the relationship between multi-
morbidity and mortality is given in figure 2. Survival was 
lower in those with multimorbidity, and the gap between 
those with and without multimorbidity was widening over 
time. The death rate per 1000 person- years is illustrated 
in table 3. There were 911 deaths in total, of which 93 
were in those with multimorbidity. The death rate per 
1000 person- years was 28.4 (95% CI 23.2 to 34.8) in those 
with multimorbidity and 5.7 (95% CI 5.3 to 6.1) in those 
without multimorbidity.
The Cox regression results of the association between 
multimorbidity and mortality is given in table 4. In the 
unadjusted model (n=9625), in relation to the reference 
group of no multimorbidity, those with multimorbidity in 
2001 had a mortality HR of 4.5 (95% CI 3.4 to 6.0). This 
was broadly unchanged when adjusted by age and gender 
(HR 4.5 (95% CI 3.7 to 5.6)). When further adjusted by 
the remaining covariates (n=5534), the finding of an asso-
ciation with mortality did not change (HR 2.5 (95% CI 
1.5 to 4.0)). All three models were statistically significant 
for the association between multimorbidity and mortality 
(p<0.001).
dISCuSSIOn
In this large population- based cohort with 146 472 person- 
years of follow- up, multimorbidity in mid- life was associ-
ated with an increased risk of premature mortality over 
a 15- year follow- up period. Multimorbidity prevalence, 
as measured using secondary care data in mid- life with a 
5 year lookback period, was close to 3%.
While our finding that multimorbidity is associated 
with mortality is consistent with others,3 13 14 the associ-
ation between multimorbidity in younger adults and 
premature mortality is less well explored in the literature. 
A recent systematic review and meta- analysis by Nunes et 
al included 26 studies and concluded that multimorbidity 
(regardless of measure) increased mortality.14 However, 
it was limited to adults aged 60 years and older.14 The 
review found that hospital- based studies showed stronger 
associations than population- based studies; however, they 
found that studies generally did not adjust adequately 
for explanatory variables,14 unlike the approach our own 
study has taken.
Much of the literature in relation to multimorbidity 
and life expectancy discusses it in terms of multimorbidity 
becoming an increasing challenge as our population ages 
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and people live longer with multiple conditions.3 14 22 23 
Our study highlights that multimorbidity in younger adults 
needs to be considered when tackling the challenge of 
premature mortality. This is particularly important given 
evidence showing the absolute number of individuals with 
multimorbidity is higher in younger adults compared 
with older adults.8–10
Multimorbidity prevalence figures in the literature vary 
widely, frequently due to the heterogeneity of measures 
used. Differences between studies in terms of the popu-
lation included, the source of the data and the design 
of healthcare systems also influence the prevalence. A 
systematic review of multimorbidity prevalence studies by 
Fortin and colleagues found figures ranged from just over 
3% to almost 100%.1 None of the included measures were 
comparable to ours.
The Barnett study found that the prevalence of multi-
morbidity was 30% in those aged 45–64 years (the age 
range most comparable to this study).8 However, this 
was a primary care population and it is reasonable to 
hypothesise that individuals in mid- life are more likely 
to use primary care services than secondary care services. 
Evidence shows that as individuals age the likelihood they 
will develop conditions severe enough to warrant admis-
sion will increase.53 Furthermore, primary care services 
in Scotland not only provide a ‘gatekeeping’ role but 
also provide care for many acute and chronic conditions 
which have previously required hospital admission.54
In univariate analysis, we found that lower childhood 
intelligence was associated with secondary care multimor-
bidity. This is consistent with other studies of childhood 
intelligence and health,55 but has not been widely studied 
for multimorbidity specifically. We found an association 
between adult social class and multimorbidity, which is 
consistent with the literature.3 56 We did not find an asso-
ciation between multimorbidity and gender, social class at 
birth, secondary school type, educational attainment or 
hangover frequency. These findings are contrary to some 
other studies, for example those finding a relationship 
between multimorbidity and gender.3 56 Our previous 
work examining self- reported multimorbidity in the 
ACONF found that it was associated with birth social class 
and education.39 This highlights that different multimor-
bidity measures capture different aspects of its burden.
There are a number of strengths and weaknesses in 
our approach. We have contributed toward addressing 
the need for large- scale longitudinal studies of multimor-
bidity and have demonstrated the role multimorbidity in 
younger adults plays in premature mortality.3 4 7 56 We used 
a large population cohort, with detailed early and mid- life 
data which were linked to high- quality Scottish SMR and 
mortality data.30 The advantages of using administrative 
data include being able to achieve a large sample size at 
relatively low cost, better population coverage and the 
ability to follow- up over long periods of time.20 Our study 
was based in Scotland (with follow- up information avail-
able from the rest of the UK). The results are likely gener-
alisable to other high- income countries with publicly 
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funded healthcare systems. However, the ACONF partici-
pants are mainly of white British or white Scottish nation-
ality, which may limit generalisability to more ethnically 
diverse settings.
We chose and adapted a tool sourced from an influ-
ential multimorbidity study.8 Given the heterogeneity 
of multimorbidity definitions and measures in the 
field, we have been careful to be explicit about our tool 
used and the reason for choosing it. This enables the 
comparison of findings across different settings and 
assists with developing consensus on the most appro-
priate measures to use in different scenarios.2 Simi-
larly, we have been clear that our measure is one of 
‘secondary care’ multimorbidity, since the data used to 
measure it are from hospital records. Individuals must 
have a hospital admission to be eligible for measure-
ment of this form of multimorbidity. But crucially we 
know which individuals have not had a hospital admis-
sion (and thus do not have this form of multimorbidity) 
and so our study population is wider than solely hospi-
talised patients. We did not include hospitalisation 
frequency in our univariate analysis or survival model 
because multimorbidity is a derived variable from 
hospital admissions (and thus the two would be highly 
correlated leading to multicollinearity).
Each discharge record provides up to six recorded 
conditions and we recognise that if more conditions 
are recorded, the prevalence of multimorbidity may be 
greater. While the accuracy of coding in the data sets is 
reasonably high, there have been issues identified with 
under- recording. Again, the prevalence of multimor-
bidity may be greater. However, the use of a 5- year look-
back period helps mitigate these issues as it allows more 
opportunities for conditions to be captured within an 
individual’s multimorbidity measure.
Another important consideration is that the time of 
coding of a condition does not necessarily reflect the inci-
dence of that condition or show that it is currently active. 
For example, in the supplementary conditions coders are 
able to include any other condition documented in the 
entire patient case note. However, it is valid to include 
these given that conditions which are not currently active 
may still impact on individuals, their use of services and 
their outcomes.8 57 58 Thus while we use the term ‘preva-
lence’, like many other studies our assessment is more of 
the ‘burden’ of multimorbidity.
Premature mortality was defined as death before the 
age of 70. Our survival analysis was to between ages 60 
and 66 years (using the full available follow- up of ACONF 
at the current time). Thus, we have likely underestimated 
the full burden of premature mortality in those with 
multimorbidity.
Missing data imputation techniques were not used to 
impute data for those without linked data or postal ques-
tionnaire data, as the data were deemed MNAR (ie, there 
was insufficient information in the data set to inform 
the mechanism of the missing data). This is the correct 
approach methodologically as imputing when data are 
MNAR may lead to as much, or even more, bias than 
CCA.59
We did not have regular status updates for the study 
population; therefore, we acknowledge that some of 
our population may have temporarily resided outside 
of Scotland during the 5- year lookback period and any 
healthcare contacts would not be recorded. This may 
underestimate the prevalence of multimorbidity. We 
hypothesise that the impact of this on our results would 
be low as it is known this cohort has a high degree of 
geographical stability.26
Our study focused on ACONF members who were 
Scottish residents to access linked hospital episode data. 
There is currently no capability to link ACONF members 
who are in the rest of the UK with their administrative 
data. However, any individuals who moved but remained 
in the UK or had a death anywhere in the UK after the 
index date could be included. A proportion of the popu-
lation were excluded as they did not have full follow- up 
information to 2016 (0.5%), but this figure is low and so 
it is unlikely to impact on our findings significantly.
The findings have a number of implications. Recent 
concerning statistics show the slowing and reversing of 
life expectancy rises in high- income countries. Drivers 
for this are complex and multifactorial (with government 
austerity measures and rising inequality described cited as 
possible factors).16–19 Our results highlight that younger 
adults with multimorbidity represent an important group 
at risk of premature mortality. It has been highlighted 
that reductions in life expectancy are more marked 
among poorer socioeconomic groups.16–18 We also found 
an association between multimorbidity and adult socio-
economic status, indicating this group may contribute 
toward inequalities in life expectancy reductions.
With evidence also showing that younger adults with 
multimorbidity may have greater healthcare needs 
than older adults with multimorbidity,11 this population 
should be an important consideration for policy- makers, 
researchers, healthcare planners and practitioners. For 
example, geriatric healthcare services can offer compre-
hensive assessment and management of older individuals 
with multiple conditions, but an equivalent for younger 
multimorbid patients generally does not exist.
There is evidence showing that multimorbidity preva-
lence is increasing over time in all age groups.60 Thus, 
while our population had multimorbidity measured in 
mid- life in 2001, the same age group now may have a 
higher proportion of multimorbidity. This may not only 
lead to a higher burden of premature mortality in the 
future, but has significant implications for individuals 
and health and social care services.
We have shown that an administrative data count 
measure of multimorbidity, sourced from secondary care 
is associated with mortality. Studying health and well- 
being across the life course at scale can be prohibitively 
expensive. This study has implications for researchers in 
showing that these relatively low- cost sources of data can 
be an important resource for research. Because there may 
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be under- recording of certain health conditions within 
the SMR data sets, efforts to supplement these data sets 
with other routinely collected secondary care data should 
be explored. For example, there is no national laboratory 
data set in Scotland, but this could be used to provide 
detail on conditions such as diabetes and chronic kidney 
disease.
In conclusion, secondary care multimorbidity in mid- 
life was associated with premature mortality over 15 years 
of follow- up in the ACONF study. We contribute toward 
addressing the need for large, longitudinal studies of 
the outcomes of multimorbidity and demonstrate the 
important role multimorbidity in younger adults plays in 
premature mortality.
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